Healthcare Systems & Policy

01 Overview & History of US Healthcare

The US healthcare system is the largest, most expensive, and most administratively complex health system in the world. It is not a single system but a patchwork of private insurers, public programs, employer-sponsored coverage, safety-net providers, and out-of-pocket spending. Understanding its structure requires understanding its history — because almost every feature of the modern system is a legacy of a specific 20th-century policy choice.

The Iron Triangle of Healthcare

A classic framework for thinking about health system tradeoffs is the Iron Triangle: access, cost, quality. The claim is that improving any two forces the third to degrade. Expand access while holding quality constant → cost rises. Reduce cost while preserving access → quality must fall. Improve quality while keeping cost flat → access shrinks. While the framework is oversimplified — technology and process improvement can occasionally improve all three — it remains a useful reference for evaluating policy proposals. The Triple Aim is in part an explicit rejection of the Iron Triangle, arguing that better coordination can escape the tradeoff.

The Healthcare "System" as an Assembly of Subsystems

Calling the US arrangement a "system" obscures its nature. It is more accurately a loose collection of subsystems that barely interoperate: Medicare FFS, Medicare Advantage, Medicaid (50 state variants), CHIP, VA, IHS, military TRICARE, federal employees (FEHB), ACA marketplaces, employer self-funded plans, employer fully-insured plans, short-term limited-duration plans, health sharing ministries, and the uninsured. Each subsystem has its own eligibility rules, benefits, networks, payment methods, regulators, and data systems. A patient can move among multiple subsystems over a year as their job, income, or health changes — each transition a potential source of coverage disruption. This fragmentation is the single most distinctive feature of US healthcare financing.

A Working Definition of "Healthcare System"

For purposes of this reference, a healthcare system is the organized set of institutions, financing mechanisms, workforce, technologies, and policies that produce and deliver health services to a population. This definition intentionally combines delivery (hospitals, clinics, clinicians), financing (insurance, taxation, out-of-pocket), governance (regulators, statutes), and outputs (care, outcomes, costs). Any analysis that separates delivery from financing or governance from outputs misses how changes in one domain ripple through the others.

Historical Milestones

Structure of the Modern System

Before Medicare: The Pre-1965 Landscape

In 1965, roughly 50% of Americans 65+ had no health insurance; those who did had coverage that typically excluded the sickest. Hospitals were financed through a mix of private payment, Blue Cross, and Hill-Burton charity obligations. Physicians operated almost entirely on fee-for-service. The AMA had successfully opposed every national health insurance proposal since Theodore Roosevelt in 1912, Truman in 1948, and the Kerr-Mills program of 1960 (a means-tested precursor to Medicaid). The 1964 landslide election of Lyndon Johnson and the collapse of the AMA's "Operation Coffee Cup" opposition (featuring Ronald Reagan's famous 1961 recording warning Medicare would lead to socialism) created the political window for Title XVIII and XIX.

The US system can be thought of as four overlapping payer pools: (1) employer-sponsored insurance (ESI) covering ~155 million people (~49% of the population); (2) Medicare covering ~65 million (elderly and disabled); (3) Medicaid/CHIP covering ~90 million (low-income); and (4) the individual market (ACA marketplaces and off-exchange) covering ~15 million. Approximately 25–28 million remain uninsured, with rates varying widely by state based on Medicaid expansion status and immigration policy.

Three Layers of Government Involvement

Healthcare governance in the US is split across federal, state, and local levels, each with distinct authority. Federal: Medicare, Medicaid financing and rules, FDA, FTC antitrust, ERISA, ACA, federal insurance regulation for self-funded plans. State: Medicaid administration, licensure of professionals and facilities, insurance commissioner regulation of fully-insured commercial plans, public health authority (quarantine, reporting), medical malpractice law, scope of practice, certificate of need (in 35 states), and Medicaid eligibility decisions. Local: public hospitals, health departments, county jails, school health, emergency medical services, behavioral health crisis response. This fragmentation creates what health policy scholars call "venue shopping" — reform advocates moving between levels depending on which is more receptive — and is a source of profound inequity because state-level choices (notably Medicaid expansion) produce dramatically different coverage outcomes for otherwise identical residents.

Insurance Coverage by Age Group

02 Triple, Quadruple & Quintuple Aim

The Triple Aim is the single most influential framework in modern US health policy. Articulated by Don Berwick and colleagues at the Institute for Healthcare Improvement (IHI) in 2008, it names the three simultaneous goals of a high-performing health system. Every value-based payment model, every ACO, every CMMI experiment, and every hospital quality program traces back to these three aims.

The Triple Aim

Why the Triple Aim Changed Policy

Before 2008, quality improvement, cost containment, and population health were treated as separate — often conflicting — agendas. The Triple Aim's central innovation was to insist they must be pursued together. A quality gain that raises cost is no gain at all if it displaces spending needed elsewhere; a cost cut that degrades quality or population health is false savings. CMMI, CMS payment reform, and state Medicaid reform designs have all embedded Triple Aim logic in their design criteria. Whether that embedding has translated into results is the ongoing evaluation question.

Operationalizing the Triple Aim

The Triple Aim is not simply a slogan — it is the framework that determines how CMS scores payment models and how health systems structure improvement work. Each aim maps to specific measurement domains: patient experience (HCAHPS, CAHPS, Net Promoter Scores, patient-reported outcome measures), population health (immunization rates, chronic disease control metrics, hospitalization rates per 1,000, disease-specific outcomes), and per-capita cost (PMPM total cost of care, trend vs benchmark, resource use). IHI has published extensively on operational approaches: creating population-level denominators, aligning incentive systems, engaging communities, integrating upstream social services, and measuring all three aims simultaneously to avoid unintended tradeoffs.

Quadruple & Quintuple Aim

In 2014, Bodenheimer and Sinsky argued the Triple Aim had failed to account for the deteriorating experience of clinicians. They added a fourth aim — improving the work life of healthcare providers — creating the Quadruple Aim. Clinician burnout directly threatens the other three aims: burned-out physicians deliver worse care, worse outcomes, and greater cost through turnover, errors, and attrition. More recently, the Quintuple Aim has been proposed, adding health equity as an explicit fifth pillar, reflecting the recognition that population-level improvements can mask widening disparities.

03 IOM Six Aims & Donabedian Framework

Two frameworks dominate US quality thinking: the Institute of Medicine (IOM) Six Aims for Improvement from the 2001 report Crossing the Quality Chasm, and Avedis Donabedian's structure–process–outcome taxonomy for quality measurement from 1966.

IOM Six Aims — STEEEP

Donabedian Framework

Avedis Donabedian proposed in 1966 that quality of care can be measured through three categories, forming a causal chain: structure → process → outcome. This taxonomy remains the backbone of all US quality measurement.

04 Comparative International Health Systems

Health systems worldwide fall into four archetypes, described by Princeton health economist Uwe Reinhardt and political scientist T.R. Reid. Understanding these models makes the US system's idiosyncrasies visible: the US is the only high-income country that uses all four models simultaneously, and the only one where the dominant model is the commercial private insurance (Bismarck-lite) arrangement without the cost controls found elsewhere.

The Four Models

Universal Coverage Mechanisms — How Other Countries Do It

Every peer OECD country achieves universal or near-universal coverage through one of three paths: (1) single-payer public insurance financed by general taxation (Canada, Taiwan, Scandinavia); (2) regulated multi-payer with sickness funds or private insurers and mandatory enrollment (Germany, France, Switzerland, Netherlands); or (3) public integrated delivery with government-owned facilities and salaried clinicians (UK NHS, Spain, Italy). All of these designs include three common elements the US does not: (a) universal enrollment (automatic or mandatory), (b) centralized price negotiation or regulation, and (c) comprehensive standardized benefits. The Swiss and Dutch systems are often cited as closest analogs to the ACA framework, though both have stronger price controls and tighter insurance regulation.

OECD Comparisons

The US spends approximately 17–18% of GDP on healthcare — roughly double the OECD average (~9%) and ~50% more per capita than the next-highest spender. Despite this, the US ranks near the bottom of peer nations on life expectancy, infant mortality, maternal mortality, and avoidable deaths. The US has fewer physicians per capita, fewer hospital beds per capita, and fewer physician visits per person than peer OECD countries, yet higher prices for almost every service and drug.

05 US Healthcare Expenditure Overview

Total US health expenditure (NHE, National Health Expenditure) reached $4.5–4.9 trillion in the mid-2020s — approximately 17–18% of GDP and roughly $13,500–14,500 per capita. For scale: US healthcare spending alone exceeds the entire GDP of all but a handful of countries. CMS's Office of the Actuary projects NHE will reach ~20% of GDP by 2032 under current policy, driven primarily by the aging of the Baby Boomer cohort into Medicare.

Key Numbers to Know

06 Spending Categories & Sources

Where the Money Goes (Spending by Category)

Where the Money Comes From (Sources of Financing)

07 Cost Drivers & Growth

Decomposing Healthcare Spending Growth

Academic decompositions of US healthcare spending growth generally allocate contributions across: demographic change (population growth and aging, ~15%), economy-wide inflation (~10%), excess medical inflation (~15%), utilization growth (~15%), intensity/technology (~30%), and residual (~15%). Note that pure "volume" (more visits, more admissions) is a minor driver — most growth comes from what is done per visit, which is largely a technology story. This reframes cost control: cutting visits alone will not solve the problem. Reducing price per service and controlling the rate of adoption of marginal-benefit technology matter more.

Why Healthcare Costs Rise

Healthcare cost growth historically outpaces general inflation by 1–3 percentage points. The reasons are well-studied and converge on a short list:

Prices vs Utilization

A central insight: the US is not a high-utilization system. Americans visit doctors less often than peer OECD residents, have shorter hospital stays, and have fewer hospital beds per capita. What distinguishes US spending is price per unit of service. A knee replacement that costs $8,000 in France or Germany costs $25,000–$40,000 in the US. A month of Humira costs ~$600 in Switzerland and ~$6,000 in the US. Imaging, ED visits, birth, MRI, and essentially every listed service follow the same pattern.

Administrative Costs

Estimates of US healthcare administrative spending range from 15% (Himmelstein) to 30% (Cutler et al., loosely defined). The sources are fragmented billing rules (~1,500 payers each with distinct contracts), prior authorization, denial management, credentialing, quality reporting, coding audits, and appeals. Single-payer systems like Canada spend ~2–3% on administration for equivalent functions.

The Waste Taxonomy (Berwick & Hackbarth, 2012)

Don Berwick and Andrew Hackbarth proposed a taxonomy of healthcare waste estimating that 30% of US healthcare spending is waste — ~$1 trillion in current dollars. Their six categories:

08 Provider Payment Mechanisms

How providers are paid fundamentally shapes how they behave. Every payment model creates incentives — some aligned with quality, some with volume, some with cost containment, none perfectly.

The Core Payment Methods

Resource-Based Relative Value Scale (RBRVS)

Medicare pays physicians via the Medicare Physician Fee Schedule (MPFS), which uses RBRVS. Each service has three RVU components: Work RVU (physician time and effort), Practice Expense RVU (overhead), and Malpractice RVU. These are summed, adjusted by a Geographic Practice Cost Index (GPCI), and multiplied by an annual Conversion Factor ($32–33 in recent years) to yield the payment. RVU weights are recommended by the AMA's RVS Update Committee (RUC), a specialty-dominated body that critics argue has systematically undervalued cognitive services vs. procedural ones.

Diagnosis-Related Groups (DRGs)

Since 1983, Medicare pays hospitals for inpatient stays via Inpatient Prospective Payment System (IPPS), using MS-DRGs (Medicare Severity DRGs). Each admission is assigned to one DRG based on principal diagnosis, procedures, and comorbidities/complications. The hospital receives a fixed payment regardless of actual length of stay or cost. This created powerful incentives to shorten LOS and avoid complications — and to code comorbidities thoroughly (driving the rise of clinical documentation improvement programs).

Outpatient and Post-Acute Payment Systems

Medicare uses distinct prospective payment systems for each setting, each with its own unit of payment and adjustments:

09 Private Health Insurance

Private health insurance covers approximately two-thirds of non-elderly Americans. It comes in two main forms: employer-sponsored insurance (ESI) — the dominant model, covering ~155 million — and individual-market coverage, purchased directly by consumers through ACA marketplaces or off-exchange.

Employer-Sponsored Insurance (ESI)

ESI is a historical accident of WWII wage controls. Employers can offer health insurance as a non-taxable benefit — the single largest tax expenditure in the federal budget (>$300B/year foregone revenue). Employers may purchase coverage from an insurer (fully-insured plans) or bear the claims risk themselves (self-funded / ERISA plans). About 65% of ESI enrollees are in self-funded plans, which are governed by federal ERISA law and largely exempt from state insurance regulation.

Individual & Small Group Market

Before the ACA, the individual market was the most dysfunctional piece of US insurance: insurers could deny coverage for pre-existing conditions, rescind coverage after claims (rescission), exclude entire conditions, charge women more (gender rating), and vary premiums wildly by health status. The ACA eliminated most of these practices — requiring guaranteed issue, community rating (with narrow age/tobacco adjustments), essential health benefits, and MLR minimums. The result: a substantially more regulated individual market accessible via Healthcare.gov or state-run exchanges.

10 Managed Care Plan Types

"Managed care" refers to insurance products that use network restrictions, utilization review, prior authorization, and primary-care gatekeeping to control cost. The major plan types differ in how restrictive they are.

Origin of Managed Care

Managed care emerged in the 1970s as a response to accelerating fee-for-service cost growth. The 1973 HMO Act provided federal grants, loans, and employer requirements that seeded HMO growth. By the mid-1990s, most employer plans had moved to some form of managed care, producing a brief cost-growth slowdown known as the managed care backlash era. Patient frustration with referral restrictions and denial practices then produced legal and political pressure that softened many managed care tools by the late 1990s — and cost growth resumed. The current era features less aggressive utilization management but narrow networks, prior authorization, and tiered formularies as the main cost-control levers.

HMO, PPO, EPO, POS, HDHP

HDHPs and HSAs

A High-Deductible Health Plan (HDHP) must have a deductible above an IRS-defined threshold (~$1,600 individual / $3,200 family in recent years) and an out-of-pocket maximum below another threshold (~$8,050 / $16,100). HDHPs qualify the enrollee for a Health Savings Account (HSA) — a triple-tax-advantaged account: contributions are pre-tax, growth is tax-free, and qualified medical withdrawals are tax-free. HSAs roll over year-to-year and are portable. A Flexible Spending Account (FSA), by contrast, is a use-it-or-lose-it employer-based account that does not require an HDHP but also does not roll over (except for a small carryover).

11 Cost-Sharing & Plan Mechanics

The Five Cost-Sharing Terms

How a Claim Flows

A patient receives care; the provider bills the insurer; the insurer applies contracted rates and adjudicates the claim; the patient owes the remaining patient responsibility (copay, deductible portion, coinsurance). The patient receives an Explanation of Benefits (EOB) showing billed amount, allowed amount, insurer payment, and patient responsibility. The allowed amount — not the billed charge — is the contracted rate the insurer has negotiated with the provider. Out-of-network claims have no contracted rate, which is where balance billing historically occurred.

Actuarial Value & Metal Tiers

ACA marketplace plans are categorized by actuarial value (AV) — the average share of covered costs the plan pays for a standard population:

12 Networks, Prior Auth & Formularies

Network Adequacy

Network adequacy standards require insurers to maintain a sufficient number of providers within reasonable time/distance of enrollees. Federal standards apply to Medicare Advantage (based on county types, provider specialties, max time/distance) and ACA marketplace plans (quantitative time/distance plus essential community provider requirements). Commercial plans are regulated by state insurance departments with varying standards. Narrow networks can be adequate on paper but inadequate in practice if "ghost networks" list providers who are not actually accepting new patients — a widely documented problem particularly for mental health providers.

Provider Networks

A network is the set of providers an insurer has contracted with at negotiated rates. In-network providers cost the patient less (contracted rates apply). Out-of-network providers cost more and historically could "balance bill" the patient for the difference between their charge and the insurer's allowed amount. Narrow networks restrict the network to a limited set of providers in exchange for lower premiums — common on ACA marketplaces.

Utilization Management Toolkit

Prior Authorization

Prior authorization (PA) is a utilization-management tool requiring providers to obtain insurer approval before delivering a service. Originally intended for expensive or discretionary services (advanced imaging, surgery, biologics), PA has expanded dramatically — an estimated 40 PA requests per physician per week. PA creates administrative burden, delays care, and has been linked to adverse outcomes. The 2024 CMS interoperability rule requires certain federal payers to respond to PA requests within set timelines and to provide electronic PA APIs.

Formularies

A formulary is the list of drugs a plan covers, organized into tiers with escalating cost-sharing:

Formulary management tools include step therapy (must try cheaper drug first), quantity limits, and therapeutic substitution. The formulary is managed by the insurer or its Pharmacy Benefit Manager (PBM), which negotiates rebates with manufacturers and keeps a share of the savings.

Risk Pooling & Rating

Community rating (ACA-style): premiums are the same for everyone in the pool, with narrow permitted adjustments (age 3:1, tobacco 1.5:1, family size, geography). Experience rating: premiums based on the enrollee's own claims history — banned in the ACA individual and small group markets but permitted in large-group markets. Underwriting: the insurer's assessment of risk before offering coverage — banned for pre-existing conditions under the ACA.

13 Medicare Overview & Eligibility

Medicare is the federal health insurance program created in 1965 (Title XVIII of the Social Security Act) for Americans aged 65 and older. It has since expanded to cover people with disabilities, end-stage renal disease (ESRD), and ALS. In the mid-2020s, Medicare covers approximately 65 million Americans and spends approximately $900 billion–$1 trillion per year.

Eligibility

Enrollment Periods

14 Parts A, B, C & D

The Four Parts of Medicare

Medicare vs Medicaid — Key Distinctions

Part A Details

Part A is funded by the 2.9% Medicare payroll tax (split 1.45% employee / 1.45% employer). It covers inpatient hospitalization using benefit periods starting on admission and ending 60 days after discharge. A beneficiary may have multiple benefit periods per year, each with its own deductible. SNF coverage requires a qualifying 3-day inpatient hospital stay ("3-day rule") and covers up to 100 days per benefit period (days 1–20 no cost; days 21–100 daily coinsurance).

The Observation Status Problem

Medicare's distinction between inpatient and outpatient observation status has major consequences for beneficiaries. Observation stays are billed under Part B (outpatient), not Part A, and do not count toward the 3-day qualifying hospital stay required for Medicare SNF coverage. A patient who spends 4 days in the hospital under observation and then is discharged to a SNF may face the full SNF bill themselves. The 2015 NOTICE Act requires hospitals to notify patients of observation status, but the underlying problem remains. The 2-midnight rule (2013) was CMS's attempt to clarify when inpatient admission is appropriate.

Part B Details

Part B covers outpatient and professional services. The standard 2024 monthly premium was ~$175, with Income-Related Monthly Adjustment Amount (IRMAA) surcharges for higher-income beneficiaries (singles >$103K, couples >$206K). After the annual deductible, Medicare pays 80% and the beneficiary 20% — with no out-of-pocket maximum in Original Medicare (a major gap filled by Medigap plans).

Assignment & Balance Billing Under Medicare

Physicians participating in Medicare can choose participating (agree to accept Medicare-approved amount as payment in full; collect 20% from patient plus any unmet deductible); non-participating (may accept assignment on case-by-case basis; if not, may charge up to 115% of the fee schedule as a "limiting charge"); or opt-out (private contract directly with patients; see no Medicare beneficiaries via Medicare billing for a 2-year period). Nearly all physicians are participating providers today because of the operational complexity and patient burden of non-participation.

Part C: Medicare Advantage

Medicare Advantage (MA) allows beneficiaries to receive Parts A and B (and usually D) through private managed care plans (typically HMOs or PPOs). CMS pays the plan a risk-adjusted capitated amount per enrollee. MA has grown to cover >50% of Medicare beneficiaries. MA plans can offer supplemental benefits (dental, vision, hearing, gym memberships, transportation) but restrict provider networks. The CMS Star Ratings (1–5) drive bonus payments to high-performing plans.

Medicare Trust Funds

Medicare is financed through two trust funds with different financing structures and solvency outlooks:

Part D: Prescription Drugs

Created by the 2003 Medicare Modernization Act, Part D is delivered by private stand-alone prescription drug plans (PDPs) or integrated into MA-PDs. Historically Part D had a coverage gap ("donut hole") between the initial coverage limit and the catastrophic threshold — largely closed by the ACA and fully replaced by the IRA $2,000 out-of-pocket cap beginning 2025. The IRA also allows Medicare to directly negotiate prices for a growing list of high-cost drugs for the first time.

Medicare Advantage Controversies

Medicare Advantage has grown from <15% of beneficiaries in 2005 to >50% today, driven by zero-premium plans, supplemental benefits (dental, vision, gym, meals), and aggressive marketing. But MA has attracted substantial criticism: (1) upcoding — MedPAC estimates MA plans code diagnoses ~5–10% more intensively than FFS Medicare for equivalent patients, inflating payments; (2) prior authorization barriers and high denial rates, particularly for post-acute care (OIG reports); (3) narrow networks that shift beneficiaries back to FFS when they become sick; (4) marketing abuses that have prompted CMS rule changes; and (5) overpayments relative to FFS estimated at ~$80 billion/year by MedPAC. Defenders note higher patient satisfaction, supplemental benefits, and integrated care advantages.

15 MACRA, QPP, MIPS & APMs

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) permanently repealed the Sustainable Growth Rate (SGR) formula — which had threatened annual physician pay cuts for 15 years — and replaced it with the Quality Payment Program (QPP). MACRA is the most important physician-payment reform since RBRVS. Under QPP, physicians choose one of two tracks:

The Two QPP Tracks

MIPS Performance Categories

Advanced APMs

An Advanced APM must use certified EHR technology, base payments on quality measures comparable to MIPS, and bear more than nominal financial risk (downside risk). Examples include MSSP ACOs in higher-risk tracks (Track 2/3, ENHANCED, REACH), BPCI Advanced, CPC+, Primary Care First, and the Kidney Care Choices model. Qualifying participants (QPs) have historically received a 5% lump-sum bonus and are exempt from MIPS reporting.

The SGR & Why MACRA Happened

The Sustainable Growth Rate (SGR), enacted in 1997, tied Medicare physician fee updates to GDP growth. When healthcare spending outpaced GDP, SGR called for automatic fee cuts. Starting in 2003, Congress passed annual "doc fixes" to override these cuts — a yearly ritual that produced enormous uncertainty for physicians, an accumulated 21%-plus shortfall by 2015, and the political pressure that finally produced MACRA. The cost of permanently repealing SGR was ~$200 billion over 10 years, offset partly through Medigap first-dollar restrictions (Plans C and F unavailable to new enrollees after 2020) and other reforms.

16 Medicaid Structure & Eligibility

Medicaid is a joint federal-state program created in 1965 (Title XIX) to provide health coverage for low-income Americans. Unlike Medicare, Medicaid is administered by states within federal parameters: each state designs its own program, sets eligibility above federal minimums, and contracts with providers. The federal government pays a share of costs — the Federal Medical Assistance Percentage (FMAP) — ranging from 50% in wealthy states to 78% in the poorest, with enhanced match rates for specific populations.

Presumptive Eligibility

Some states permit presumptive eligibility, under which qualified entities (hospitals, FQHCs, WIC agencies) can temporarily enroll individuals who appear to meet Medicaid criteria pending formal verification. This reduces coverage delays at the point of care and is particularly useful for pregnant women, children, and hospitalized patients encountered in the safety net.

Categorical vs Income Eligibility

Traditional Medicaid is categorical: eligibility requires fitting into a covered category (pregnant, parent of dependent child, elderly, disabled, child) plus meeting income and asset tests. The ACA expansion broke this categorical rule by covering adults 0–138% FPL regardless of category — the first time childless non-disabled adults became broadly eligible. In non-expansion states, the categorical framework persists, which is why a childless adult earning $5,000/year may be ineligible for Medicaid while a similarly situated adult in a neighboring expansion state qualifies automatically.

The FMAP Mechanism

The Federal Medical Assistance Percentage (FMAP) is the share of Medicaid service costs the federal government pays. It is set by formula based on state per-capita income relative to the national average, with a minimum of 50% (wealthy states) and a maximum of 83%. The actual FMAP in most states runs 50–78%. Special enhanced match rates apply to specific populations/services: 90% for the ACA expansion population (childless adults 0–138% FPL), E-FMAP (enhanced) for CHIP (~15 points above regular FMAP), 100% for services provided to American Indians/Alaska Natives through IHS or tribal facilities, and 75–90% for family planning and certain HCBS. The ACA's 90% expansion match is the most generous federal matching rate in traditional Medicaid history and is a principal reason for the aggressive expansion trajectory in the 2020s.

Eligibility Categories

Federal Poverty Level (FPL) Thresholds

The Federal Poverty Level is updated annually by HHS and determines eligibility for many programs. Key thresholds:

ACA Medicaid Expansion Status

As of the mid-2020s, roughly 40 states plus DC have expanded Medicaid under the ACA. The approximately 10 non-expansion states — concentrated in the South — have the highest uninsured rates and the largest coverage gaps. Studies published after expansion consistently show reductions in uninsured rates, improved access to primary and preventive care, earlier diagnosis of chronic disease, reductions in medical debt and bankruptcies, and mortality reductions in expansion states compared to non-expansion states. The North Carolina (2023) and South Dakota (2023) expansions represent the continued — if slow — political movement toward complete national expansion.

Mandatory vs Optional Benefits

Federal law requires states to cover specific populations and services (mandatory), with a broader menu of optional populations/services that states may cover. Mandatory services include inpatient/outpatient hospital, physician services, lab/X-ray, nursing facility, home health, family planning, and EPSDT (Early and Periodic Screening, Diagnostic, and Treatment) for children under 21. Prescription drugs, dental, vision, PT/OT, and hospice are technically optional but covered by almost all states.

17 Medicaid Waivers, Managed Care & LTC

Medicaid Waivers

Federal Medicaid statute allows waivers that let states modify standard rules. The two most important:

Medicaid Managed Care

More than 70% of Medicaid enrollees are in managed care organizations (MCOs). States contract with private insurers (often the same national carriers running commercial and MA plans) paying a capitated PMPM rate. Managed Medicaid has grown because it gives states budget predictability and shifts utilization risk to insurers.

Long-Term Services & Supports (LTSS)

Medicaid is the largest single payer for long-term care (LTC) in the US — covering ~60% of nursing home residents. Medicare does not cover long-term custodial care (only up to 100 post-hospitalization SNF days). To become eligible for Medicaid LTC, applicants typically must "spend down" assets to state-specific thresholds. HCBS waivers allow care in the home/community rather than institutional settings, reflecting the post-Olmstead (1999) requirement that states provide services in the most integrated setting appropriate.

18 CHIP & Dual Eligibles

Medicaid MCO Procurement

States contract with Medicaid MCOs through competitive procurement, typically running 3–5 year contracts with extensions. MCOs bid on regions or populations and must meet network adequacy, quality reporting, and medical loss ratio minimums. The national Medicaid MCO market is dominated by a handful of large insurers — Centene, UnitedHealthcare Community & State, Elevance (Anthem), Molina, Humana, and CVS/Aetna together cover the majority of Medicaid managed care lives. Procurement outcomes are often litigated because of the multi-billion-dollar contract values at stake.

CHIP

The Children's Health Insurance Program (CHIP), created in 1997 (Title XXI), covers children in families with income too high for Medicaid but too low to afford private coverage — typically up to 200–300% FPL depending on state. States can run CHIP as a Medicaid expansion, a separate program, or a hybrid. CHIP covers ~7 million children and has contributed to the historically low uninsured rate among US children (~5%). The federal match rate (E-FMAP) is higher than regular Medicaid.

Dual Eligibles

Dual eligibles are individuals enrolled in both Medicare (primary payer) and Medicaid (secondary payer / wrap-around). There are ~12 million dual eligibles. They are among the most medically complex and expensive patients in the US healthcare system — representing ~20% of Medicare enrollees but ~34% of Medicare spending, and ~15% of Medicaid enrollees but ~30% of Medicaid spending. Medicaid pays Medicare premiums, cost-sharing, and fills coverage gaps (notably LTC, dental).

Integrated care programs for dual eligibles include D-SNPs (Dual-eligible Special Needs Plans, a Medicare Advantage product), PACE (Programs of All-Inclusive Care for the Elderly), and state-based Medicare-Medicaid integration demonstrations through CMMI's Financial Alignment Initiative.

PACE Programs

PACE (Program of All-Inclusive Care for the Elderly) is a fully capitated, comprehensive care model for individuals 55+ who are nursing home eligible but living in the community. A PACE organization receives combined Medicare and Medicaid capitation and is responsible for all needed medical, behavioral, and long-term services. PACE participants typically attend an adult day health center where they receive primary care, therapy, socialization, and meals. Outcomes data show lower hospital use, longer community tenure, and high patient satisfaction. PACE is one of the longest-running and most clinically successful integrated care models in the US, though scale has been limited by eligibility restrictions and enrollment complexity.

Medicaid Provider Taxes and Financing Mechanics

Because Medicaid is jointly financed (FMAP matching), states face a powerful incentive to maximize federal draw. Provider taxes (allowed up to 6% of provider revenues under federal rules) are assessed on hospitals, nursing homes, or MCOs; the revenue is used as the state share, which then draws down federal matching funds and is often returned to the same providers as supplemental payments. This creates a circular but legal financing arrangement that has expanded substantially since the 1990s. Intergovernmental transfers (IGTs) from local public hospitals and certified public expenditures (CPEs) are other mechanisms states use to leverage federal funds. Critics call these arrangements "Medicaid financing gimmicks;" supporters argue they are essential for safety-net sustainability.

19 ACA Coverage Provisions

The Patient Protection and Affordable Care Act of 2010 (ACA) is the largest US healthcare reform since 1965. It restructured the individual insurance market, created marketplaces, expanded Medicaid, introduced coverage mandates, and imposed new insurance regulations. Some ACA provisions have since been weakened or repealed (e.g., individual mandate penalty reduced to $0 in 2019) but the core framework remains.

Coverage Expansion Provisions

The Metal Tiers & AV Design

The ACA's metal tier system is designed to let consumers shop on total cost (premium plus expected out-of-pocket) rather than just premium alone. A bronze plan has a low premium but ~40% of costs fall on the patient; a platinum plan has a high premium but only ~10% falls on the patient. The benchmark silver plan is used to calculate premium tax credits specifically because it represents a middle-of-the-road option. Silver plans also receive the CSR enhancements that raise effective AV for low-income enrollees. The result is that for most subsidized enrollees, the optimal plan choice is silver — except when silver loading has made bronze or gold relatively more attractive post-2017.

Essential Health Benefits

ACA individual and small group plans must cover ten categories of Essential Health Benefits (EHBs):

Preventive Services

Under the ACA, non-grandfathered plans must cover specified preventive services with no cost-sharing to the patient. These are defined by (1) USPSTF grade A or B recommendations, (2) ACIP immunization schedule, (3) HRSA Bright Futures for children, and (4) HRSA women's preventive services. This has eliminated out-of-pocket costs for screening colonoscopies, mammograms, cervical cancer screening, vaccines, contraception, and more for most privately insured patients.

Insurance Reforms

20 Marketplaces, Subsidies & Mandates

Health Insurance Marketplaces

Marketplaces (exchanges) are regulated online markets where individuals can compare and purchase ACA-compliant individual coverage. States could elect to run their own (state-based marketplaces, e.g., Covered California) or default to the federal platform (Healthcare.gov). Marketplace plans are organized into metal tiers (bronze/silver/gold/platinum/catastrophic) by actuarial value.

Premium Tax Credits (PTCs)

PTCs are refundable, advanceable tax credits that cap the enrollee's required premium contribution as a percent of income, using the second-lowest-cost silver plan (the "benchmark") as the reference. Before ARPA (2021), credits were limited to 100–400% FPL with a "subsidy cliff" above 400%. ARPA (and then the IRA through 2025) eliminated the cliff and increased subsidy generosity — no one pays more than 8.5% of income for the benchmark silver plan.

Cost-Sharing Reductions (CSRs)

CSRs reduce deductibles, copays, and out-of-pocket maximums for silver-plan enrollees below 250% FPL. Low-income enrollees effectively receive higher-AV versions of their silver plan (up to 94% AV for the lowest incomes). The federal government stopped directly paying insurers for CSRs in 2017, leading insurers to "silver load" the cost into silver premiums — which paradoxically increased benchmark subsidies and made bronze/gold plans more attractive relative to silver.

Individual & Employer Mandates

The individual mandate required most Americans to maintain minimum essential coverage or pay a penalty, upheld as a tax by NFIB v. Sebelius (2012). The Tax Cuts and Jobs Act of 2017 reduced the federal penalty to $0 starting 2019, effectively eliminating it (some states — CA, MA, NJ, RI, DC — impose their own). The employer mandate requires Applicable Large Employers (ALEs, ≥50 FTEs) to offer affordable minimum-value coverage to full-time employees or face IRS penalties (Section 4980H).

21 Insurance Market Regulations

Medical Loss Ratio (MLR)

The MLR requires insurers to spend at least 80% (individual/small group) or 85% (large group) of premium revenue on medical claims and quality improvement — with rebates to consumers if they fall short. MLR has returned billions in rebates since 2011. Its limitation is that it incentivizes higher claims spending (making the denominator larger grows the allowable profit margin in dollar terms).

Rate Review & Risk Adjustment

ACA required states (or HHS in default states) to review proposed premium increases of 10% or more. The ACA also created three market-stabilization programs called the 3Rs:

Section 1332 State Innovation Waivers

Section 1332 allows states to waive certain ACA requirements to pursue alternative coverage strategies, provided they maintain comprehensive coverage, affordability, and numbers of covered people at least equivalent to the ACA baseline, without increasing federal deficit. Many states have used 1332 waivers to create state reinsurance programs that have reduced marketplace premiums.

Grandfathered & Grandmothered Plans

Grandfathered plans are those in effect when the ACA was signed (March 23, 2010) that have not substantially changed benefits or cost-sharing. They are exempt from many but not all ACA requirements (e.g., still must cover dependents to 26, cannot rescind coverage, no lifetime limits, but not required to cover preventive services without cost-sharing or adhere to EHB rules). Grandmothered (or "transitional") plans were created by Obama administration guidance allowing non-compliant pre-2014 individual and small-group plans to continue temporarily after the "if you like your plan you can keep it" backlash. These remain available in some states with annual renewal.

Notable Supreme Court Decisions Shaping the ACA

22 Alternative Payment Models

Alternative Payment Models (APMs) are reimbursement approaches that move away from pure fee-for-service, linking provider payment to quality and cost performance. They form a spectrum from modest FFS adjustments to full population risk.

Volume to Value — The Payment Reform Arc

The conceptual arc of US payment reform runs from pure volume-based payment (FFS) through increasing degrees of quality adjustment and population accountability toward full capitation. HHS set a formal target in 2015 to move 50% of Medicare payments to APMs by 2018 and nominally met it, though much of the progress came from upside-only ACOs with modest risk. The newer CMS target is that 100% of Original Medicare beneficiaries should be in an accountable care relationship by 2030. Whether this goal is realistic depends on expanding two-sided risk models among primary care practices that have so far been reluctant to accept downside risk.

The HCP-LAN APM Framework

The Health Care Payment Learning & Action Network (HCP-LAN) categorizes payment models into four categories:

Why Payment Reform Is Hard

Payment reform repeatedly runs into a handful of structural challenges: (1) attribution — assigning a patient to a single accountable entity is technically and politically difficult; (2) risk adjustment — imperfect risk adjustment rewards coding over care; (3) benchmarking — historical benchmarks disadvantage high performers and reward high spenders; (4) sample size — small practices have insufficient patients for stable measurement; (5) data lag — payment signals arrive 1–2 years after the care decision; (6) leakage — attributed patients can seek care outside the accountable entity; and (7) gaming — any target creates incentives to optimize the measurement rather than the underlying goal. Successful programs address most or all of these challenges simultaneously; unsuccessful ones fail on one or more.

Bundled / Episode-Based Payments

A bundled payment covers all services across an episode of care (e.g., 90 days around a joint replacement, including the procedure, implants, rehabilitation, and readmissions). Providers who deliver the episode under budget keep the savings; those who exceed it bear losses. CMS programs include BPCI (Bundled Payments for Care Improvement), BPCI Advanced, and the mandatory Comprehensive Care for Joint Replacement (CJR) model for hip/knee replacements.

Shared Savings vs Shared Risk

23 ACOs & CMMI Innovation Models

Accountable Care Organizations

An Accountable Care Organization (ACO) is a group of providers who collectively accept responsibility for the cost and quality of care for a defined population — typically assigned based on plurality of primary care utilization. If the ACO delivers care under a cost benchmark while meeting quality targets, it shares in the savings; depending on the model, it may also share in losses.

Major Medicare ACO Models

Patient-Centered Medical Home (PCMH)

The PCMH is a primary-care delivery model emphasizing comprehensive, continuous, coordinated, patient-centered care, typically recognized by NCQA. PCMHs are often paired with per-member-per-month care management fees in addition to FFS, and frequently serve as the foundation for ACO primary care.

ACO Key Mechanics

An ACO is defined by several interlocking mechanics: (1) beneficiary attribution, typically based on plurality of primary care E&M visits in the prior year; (2) a cost benchmark derived from the historical spending of attributed beneficiaries, trended forward; (3) a minimum savings rate (MSR) that must be exceeded before shared savings are paid; (4) a quality gate — the ACO must meet quality thresholds to earn shared savings; (5) risk adjustment (HCC-based); and (6) a shared savings/loss rate (e.g., 50% sharing in Basic Track E). The benchmark trending methodology is crucial: ACOs are measured against themselves, so year-over-year improvement is harder to achieve than catching up to a national average.

CMMI

The Center for Medicare & Medicaid Innovation (CMMI) — created by Section 3021 of the ACA — has authority to test payment and delivery models, and if shown to reduce cost without harming quality (or vice versa), to expand them nationally without requiring new legislation. Notable CMMI models beyond ACOs include CPC+ and Primary Care First (primary care), Maryland Total Cost of Care (statewide global budget), OCM (Oncology Care Model), Kidney Care Choices, and the Making Care Primary model.

ACO Financial Performance — In Detail

MSSP ACO performance has been modest but positive in aggregate. Recent year results show ~60–70% of MSSP ACOs earning shared savings payments and ~30–40% generating net losses to CMS after accounting for the shared-savings payout. Physician-led ACOs outperform hospital-led ACOs consistently, a finding attributed to the fact that hospital-led ACOs face internal conflicts between the shared-savings incentive and the inpatient revenue loss when utilization drops. Rural ACOs, ACOs serving dual eligibles, and ACOs in high-spending regions also tend to perform better because their benchmarks leave more room for reduction.

24 Quality Measures & Risk Adjustment

Major Quality Measurement Programs

HEDIS and Its Reach

HEDIS is the most widely used health plan measurement set in the US. It is developed and maintained by NCQA and updated annually. HEDIS covers six domains: effectiveness of care (e.g., diabetes HbA1c control, hypertension control, cancer screening, immunization rates), access/availability, experience of care, utilization, health plan descriptive information, and measures collected using electronic clinical data. HEDIS measures are used in Medicare Advantage Star Ratings, Medicaid MCO contracts, commercial accreditation, and most employer health plan evaluations. Because HEDIS drives payment and accreditation, it is a powerful lever shaping what gets measured and therefore what gets done in population health.

Types of Measures

Measures align with the Donabedian framework: structural (nurse staffing, EHR use), process (appropriate screening, antibiotic timing), outcome (mortality, readmission, infection), and patient experience (CAHPS/HCAHPS). Outcome measures are the most meaningful but require risk adjustment to be fair across providers serving different populations.

HCC Risk Adjustment

Hierarchical Condition Categories (HCCs) are the CMS risk-adjustment model used to adjust capitated payments in Medicare Advantage and ACOs for the expected cost of each beneficiary based on their diagnoses. Each HCC has a coefficient; the sum of HCCs plus demographic factors yields a risk score, normalized around 1.0. Proper HCC coding materially affects payment — which has created both legitimate coding improvement programs and well-documented "upcoding" controversies in Medicare Advantage.

Hospital-Based Value Programs

Medicare operates three mandatory hospital value-based programs that apply penalty/bonus adjustments to IPPS payments:

HRRP has been the subject of vigorous debate: it reduced 30-day readmissions meaningfully, but observational studies have suggested unintended increases in post-discharge mortality for heart failure. Later studies using different methods contest this. The program remains in place with adjustments for socioeconomic factors (peer grouping by dual-eligible share).

Patient Safety Frameworks

The modern patient safety movement traces to the 1999 IOM report To Err Is Human, which estimated 44,000–98,000 annual deaths from preventable medical errors. Subsequent work (Makary, James) has suggested much higher figures. Core safety frameworks include Swiss Cheese Model (Reason — errors align through layered defenses), high-reliability organizations (HROs) (preoccupation with failure, reluctance to simplify, sensitivity to operations, commitment to resilience, deference to expertise), Just Culture (distinguishing human error, at-risk behavior, and reckless behavior), and Root Cause Analysis (RCA) for adverse event investigation.

25 Workforce, GME & Safety Net

Specialty Distribution and Pipeline

US physician workforce composition is a legacy of both training capacity and payment incentives. Primary care (family medicine, general internal medicine, general pediatrics) comprises ~35% of active physicians and ~33% of residency training slots. Cognitive specialties (primary care, infectious disease, endocrinology, rheumatology, geriatrics) are systematically undercompensated relative to procedural specialties, driving workforce imbalances. Average income ratios for procedural to cognitive specialties run roughly 2–3:1, and income is the single strongest predictor of specialty choice among US medical graduates. Proposals to rebalance include reforming the RUC process, direct primary care capitation, expanding Title VII training grants, loan forgiveness via NHSC, and enhanced Medicaid primary care payment parity (ACA provision that has lapsed in most states).

Physician Workforce

The US has approximately 1 million active physicians — roughly 2.6 per 1,000 population, below the OECD average (~3.5). The specialty distribution is skewed toward specialists (~65%) vs. primary care (~35%), the opposite of most high-performing health systems. Geographic distribution is also uneven, with substantial Health Professional Shortage Areas (HPSAs) in rural and inner-urban regions.

GME Financing

Graduate medical education (residency) is financed primarily by Medicare GME payments (~$15 billion/year), split into Direct GME (DGME) for resident salaries/benefits/faculty and Indirect Medical Education (IME) adjustments to hospital DRG payments to reflect the higher costs of teaching hospitals. The total number of Medicare-funded residency slots has been largely frozen since the 1997 Balanced Budget Act — creating a chronic bottleneck between US medical school graduates (including IMGs) and available training positions.

340B Drug Pricing Program

Created by Section 340B of the 1992 Public Health Service Act, the 340B program requires drug manufacturers to offer outpatient drugs at discounted prices (~20–50% below average manufacturer price) to eligible safety-net providers: DSH hospitals, children's hospitals, cancer hospitals, CAHs, sole community hospitals, rural referral centers, FQHCs, RHCs, Ryan White clinics, STD/TB clinics, and certain others. Participating entities can then dispense these drugs to all their outpatients (not only low-income) and keep the spread between the 340B price and the payer reimbursement. The program has grown from ~$2 billion in the early 2000s to >$50 billion in recent years, and is the subject of intense controversy over whether the savings are actually used for charity care. Recent Supreme Court cases (AHA v. Becerra) limited HHS's ability to cut 340B reimbursement for hospitals.

Rural Health & Safety Net

Uncompensated Care

Uncompensated care is the sum of charity care (waived charges) and bad debt (billed but unpaid). US hospitals report ~$40 billion/year in uncompensated care. Much is offset by Medicaid DSH payments, Medicare DSH and bad debt payments, and non-profit hospital tax exemptions (which require demonstrated community benefit under ACA Section 9007).

Non-Physician Workforce

The US healthcare workforce extends far beyond physicians: ~4 million registered nurses, ~300,000 nurse practitioners, ~150,000 physician assistants, and millions of allied health workers (MAs, techs, therapists, home health aides). Scope of practice is regulated by state and varies dramatically: ~27 states grant NPs "full practice authority" (independent practice without physician supervision); others require collaborative agreements. The COVID PHE temporarily expanded many scope-of-practice rules; some of those expansions have become permanent. Workforce shortages in nursing, behavioral health, and rural primary care are among the most acute current health workforce problems.

Social Determinants of Health

Social determinants of health (SDOH) are the non-medical factors that shape health outcomes: housing, food security, income, education, transportation, neighborhood safety, and social support. Evidence from the County Health Rankings and other sources suggests that medical care accounts for only ~10–20% of health outcomes, with behaviors (~30%), social/economic factors (~40%), and physical environment (~10%) accounting for the rest. Under value-based payment, ACOs and MA plans increasingly invest in SDOH interventions (food pantries, housing support, transportation) as a cost-containment strategy. New ICD-10 Z-codes (Z55–Z65) allow documentation of SDOH in clinical records.

26 Price Transparency, Surprise Billing & Drug Pricing

Price Transparency

CMS rules effective 2021–2022 require hospitals to publish machine-readable files of all negotiated rates by payer, and payers to provide consumer cost-estimator tools. Compliance has been uneven, but the data have already transformed academic research on hospital pricing — revealing that prices for identical services vary 5–10× even within the same hospital across payers.

The No Surprises Act

Effective January 2022, the No Surprises Act (NSA) protects patients from most balance billing in three scenarios: (1) emergency services at out-of-network facilities, (2) out-of-network providers at in-network facilities (e.g., anesthesiologists, radiologists, pathologists), and (3) air ambulance services. Patients are held harmless at in-network cost-sharing; disputes between insurers and out-of-network providers are resolved through an Independent Dispute Resolution (IDR) process — itself a source of ongoing litigation.

Why US Drug Prices Are High

Several structural factors drive US drug prices above all peer nations: (1) the US does not centrally negotiate drug prices (until the IRA's narrow provision); (2) Medicare Part D law historically prohibited direct negotiation (the "non-interference" clause); (3) long patent terms and patent-thicket strategies delay generic entry; (4) biologics get 12 years of data exclusivity vs 8 in the EU; (5) direct-to-consumer advertising (legal only in the US and New Zealand) drives demand; (6) fragmented payers have less leverage than single payers; and (7) PBMs' rebate-based business model creates incentives for higher list prices. The typical new branded drug launches at a list price 3–5× higher in the US than the same drug in comparable markets.

Drug Pricing

US drug prices are the highest in the world — typically 2–4× OECD averages for brand-name drugs. The IRA (2022) made the most significant drug-pricing changes in Medicare history:

The Drug Supply Chain

PBMs

Pharmacy Benefit Managers (PBMs) negotiate with manufacturers on behalf of insurers, manage formularies, contract with pharmacies, and process claims. Three PBMs control ~80% of prescriptions. PBMs earn revenue through manufacturer rebates, spread pricing, and pharmacy fees. The opacity of PBM economics is a major current policy debate; recent legislation and FTC actions have targeted PBM practices.

27 Consolidation, Telehealth & Digital Health

Healthcare Antitrust

Healthcare consolidation enforcement is split between the FTC (physician practices, insurers, most providers) and DOJ (hospital mergers, certain vertical cases). FTC challenges to hospital mergers have had a mixed record; major wins include ProMedica/St. Luke's (2014) and the 2022–2024 wave of challenges to practice acquisitions by private equity-backed rollups. The 2023 Merger Guidelines (FTC/DOJ) incorporated specific language on labor-market effects and serial acquisitions, strengthening healthcare merger review. Ongoing debates include non-compete clauses for physicians (the FTC proposed a nationwide ban in 2024) and vertical integration remedies.

Hospital and Physician Consolidation

US healthcare has undergone massive consolidation since 2000: hospitals have merged into large systems, physician practices have been acquired by hospitals and insurers, and vertically integrated conglomerates (UnitedHealth/Optum is now the largest employer of physicians in the US with >70,000 employed or affiliated). The literature is clear: hospital consolidation raises prices without improving quality (Gaynor, Cooper, Capps). Vertical integration effects are more contested.

Private Equity in Healthcare

Private equity has moved aggressively into emergency medicine, anesthesiology, radiology, dermatology, ophthalmology, dentistry, nursing homes, and hospitals. Studies link PE ownership to higher prices, higher patient volumes, staffing reductions, and in some settings higher mortality (particularly nursing homes). PE roll-ups have fueled surprise-billing controversies and several prominent bankruptcies (Steward, Envision).

Telehealth Regulatory Layers

Telehealth

Before 2020, Medicare covered telehealth narrowly (rural, specific sites). The COVID-19 PHE triggered massive temporary expansions — parity payment, coverage from home, audio-only, cross-state licensing flexibilities. Most flexibilities have been extended by Congress through 2024–2025 with uncertain permanent status. The central policy debate is whether telehealth reduces cost (by substituting for in-person visits) or increases it (by adding visits), with evidence leaning toward modest additive effects.

AI and Digital Health

FDA regulates AI/ML-based Software as a Medical Device (SaMD) through a risk-based framework, with >500 AI-enabled devices authorized as of mid-2020s. Payer coverage of AI tools is catching up: CMS has created limited CPT codes and new technology add-on payments (NTAP) for specific AI products. Key policy questions include liability, bias audit requirements, FDA pre-certification pilots, and the role of AI in coverage decisions.

Integrated Delivery Systems & Vertical Integration

An Integrated Delivery System (IDS) combines a health plan, hospitals, physician groups, and sometimes post-acute and pharmacy services under shared ownership or close alignment. Classic examples include Kaiser Permanente (the archetypal staff-model HMO, ~13 million members), Geisinger, Intermountain, Marshfield Clinic, and HealthPartners. More recently, vertical conglomerates have formed at unprecedented scale: UnitedHealth Group owns UnitedHealthcare (insurer), Optum Rx (PBM), Optum Health (~70,000 physicians, largest employer of physicians in the US), and ambulatory surgery centers. CVS Health owns Aetna (insurer), Caremark (PBM), MinuteClinic, Oak Street Health, and Signify Health. Cigna owns Express Scripts (PBM) and EviCore (utilization management). This level of integration is new and raises fresh antitrust and quality-of-care questions.

EHR Adoption & Information Blocking

The 2009 HITECH Act created Meaningful Use incentive payments (later renamed Promoting Interoperability) that drove EHR adoption from ~10% of hospitals in 2008 to >95% today. Epic and Oracle Cerner dominate the hospital market; several mid-size vendors compete for ambulatory. The 21st Century Cures Act (2016) prohibited information blocking — practices likely to interfere with the access, exchange, or use of electronic health information — and required access to EHI via standard APIs (FHIR). ONC enforcement has begun issuing penalties under these rules, reshaping data-sharing practices across health IT vendors and providers.

Burnout and the Quadruple Aim

Clinician burnout reached crisis levels through the 2010s and accelerated during the COVID-19 pandemic. Drivers include documentation burden, EHR inefficiency, prior authorization workload, loss of autonomy with employed practice, productivity pressures, and moral distress. The 2019 NAM report Taking Action Against Clinician Burnout frames burnout as a system problem, not an individual resilience problem, and has shaped post-pandemic workforce policy. The US Surgeon General's 2022 advisory on healthcare worker burnout and the NAM's clinician well-being initiative have given the Quadruple Aim institutional traction.

28 Key Agencies, Legislation & High-Yield Review

Key Federal Agencies

Landmark Legislation — Quick Reference

Health Policy Process

Federal health policy moves through a predictable but slow process: agenda setting (reports, crises, advocacy), policy formulation (bill drafting, CBO scoring, committee markups), adoption (House and Senate passage, conference committee, presidential signature), implementation (HHS rulemaking under the Administrative Procedure Act — NPRM, comment period, final rule, effective date), evaluation (OIG, GAO, CMMI, independent researchers), and revision. Major laws are commonly passed through budget reconciliation (requiring only 51 Senate votes) when filibuster-proof majorities are unavailable — the ACA's reconciliation "side-car" and the IRA are recent examples. The Chevron doctrine, which directed courts to defer to agency interpretations of ambiguous statutes, was overturned in Loper Bright Enterprises v. Raimondo (2024), significantly expanding judicial review of HHS rules.

Federal Budget Impact

Federal healthcare spending — primarily Medicare, Medicaid, ACA subsidies, VA, IHS, and CHIP — now exceeds $1.6 trillion/year and is the single largest category of federal spending, surpassing Social Security and defense. Medicare alone is projected to grow from ~15% to >17% of federal spending over the next decade. The interaction with the federal debt service, the aging Baby Boomer cohort, and demographic trends is the core fiscal challenge of the coming decades. CBO projections of healthcare cost growth are the single most important input to long-run federal budget projections.

International Benchmarks — Detail

Acronym Glossary

High-Yield Policy Debates

Final Synthesis

The US healthcare system is best understood as the accumulation of 90 years of incremental policy choices rather than the product of deliberate design. Employer insurance (WWII wage freeze), Medicare/Medicaid (1965 compromise), ERISA preemption (1974 pension reform), DRGs (1983 inpatient cost control), Medicare Part D (2003), ACA (2010), MACRA (2015), and IRA (2022) each added a layer without removing previous ones. The result is a system that spends more than any peer nation, covers less of its population, achieves worse outcomes, and remains one of the most consolidated sectors of the US economy. Every clinical decision made at the bedside occurs inside this financing architecture, and every attempt at meaningful reform runs into the entrenched interests and path dependencies created by the previous layers.

Emerging Trends

High-Yield Exam Facts

Key Thought Leaders & Organizations

Common Misconceptions

Ten Numbers Every Clinician Should Know

Clinical Pearls Collection

Putting It All Together — A Walk Through the Money Trail

Consider a single patient encounter to see how all of this fits together. A 68-year-old woman with diabetes, hypertension, and early CKD goes to her primary care doctor for her Medicare Annual Wellness Visit. She is enrolled in a Medicare Advantage HMO operated by a national insurer; her PCP is part of an ACO (REACH track) affiliated with a nonprofit health system. During the visit, the PCP documents her chronic conditions (updating her HCC coding for risk adjustment), orders a basic metabolic panel, updates her medication list, and schedules an eye exam with a dilated retinal screen. She will also see endocrinology next month for an insulin pump evaluation.

Here is what just happened financially: (1) CMS paid her MA plan a capitated monthly amount risk-adjusted by her HCCs — the more conditions documented annually, the higher the payment; (2) the MA plan pays the PCP practice a combination of FFS for the visit (via the MPFS RBRVS fee schedule), a PMPM care management fee, and shared savings/losses based on quality and total cost; (3) the ACO will measure her diabetes HbA1c and blood pressure control as HEDIS-style quality measures affecting its MSSP bonus; (4) her Part D plan (bundled into the MA) will cover her metformin and insulin, with the insulin copay capped at $35 under IRA; (5) her total out-of-pocket for the year will be capped by her MA plan's OOP maximum (which MA plans must have — unlike Original Medicare); (6) the laboratory will bill the MA plan under the Clinical Lab Fee Schedule; (7) the ACO will care about her admission avoidance because inpatient spending counts against its benchmark; and (8) every one of these transactions is recorded in electronic data that will be reported across HEDIS, STAR, and ACO quality programs.

This is the system. Every participant — patient, physician, practice, ACO, MA plan, CMS — is responding to a specific set of payment and measurement signals. The clinical decision (how to manage her diabetes) is made in a financial architecture that shapes what resources are available, what gets documented, what gets measured, and what gets paid. A clinician who ignores this architecture will be surprised by denials, lost revenue, and frustrated patients. A clinician who understands it can make decisions that improve both outcomes and financial sustainability simultaneously.

Synthesis

The US healthcare system is best understood as the accumulation of 90 years of incremental policy choices rather than the product of deliberate design. Employer insurance (WWII wage freeze), Medicare/Medicaid (1965 compromise), ERISA preemption (1974 pension reform), DRGs (1983 inpatient cost control), Medicare Part D (2003), ACA (2010), MACRA (2015), and IRA (2022) each added a layer without removing previous ones. The result is a system that spends more than any peer nation, covers less of its population, achieves worse outcomes, and remains one of the most consolidated sectors of the US economy. Every clinical decision made at the bedside occurs inside this financing architecture, and every attempt at meaningful reform runs into the entrenched interests and path dependencies created by the previous layers.